Panacea Innovation Ltd
SEC CIK 2010692 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 10% | 1.01M | $670.5K | $3.17M | 6 | 2025-08-15 | 2026-05-07 |
Most active insiders at ATRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 10% | $4.74M | — |
| 2 | Panacea Innovation Ltd | 10% | — | $3.17M |
| 3 | Cherry Brian N | Dir | $1000.0K | — |
| 4 | Huang James | Dir, 10% | — | $489.0K |
| 5 | Nguyen AnhCo | Pres, CEO, Dir | — | $142.4K |
| 6 | Grant-Huerta Yanina | CAO | — | $56.5K |
| 7 | Ciongoli Gregory Austin | Dir, 10%, See Remarks | — | — |
| 8 | Redmile Group, LLC | Dir | — | — |
| 9 | Fust Matthew K | Dir | — | — |
| 10 | HEIDEN WILLIAM K | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-11 18:45 | 2026-05-07 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | S - Sale | $10.10 | -313.4K | 1.01M | -24% | -$3.17M |
| DI | 2026-03-19 | 2026-03-17 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | M - OptEx | $0.00 | +259.2K | 307.9K | +532% | $0 |
| DI | 2026-03-19 | 2026-03-17 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | F - Tax | $5.23 | -5 | 307.9K | -0.0% | -$26.15 |
| DI | 2025-12-01 | 2025-11-28 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | F - Tax | $14.03 | -1 | 48.7K | -0.0% | -$14.03 |
| DI | 2025-12-01 | 2025-11-28 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | M - OptEx | $0.00 | +48.7K | 48.7K | New | $0 |
| I | 2025-08-19 | 2025-08-15 | ATRA | Atara Biotherapeutics, Inc. | Panacea Innovation Ltd | 10% | P - Purchase | $12.19 | +55.0K | 1.41M | +4% | +$670.5K |
Purchase Sale Sale after option exercise All abbreviations